Breast Cancer Age Impact on Results and Efficacy of Dual Anti-HER2 Targeted Therapy in Adjuvant Setting Jun 09, 2023
Breast Cancer QoL in HR+/HER2- Advanced Breast Cancer: Ribociclib vs. Abemaciclib as 1L Treatment Jun 09, 2023
Breast Cancer Patient-Reported Outcomes in PIK3CA-Mutated HR+/HER2- Advanced Breast Cancer Jun 09, 2023
Breast Cancer,HER2+ Margetuximab vs Trastuzumab in Pretreated ERBB2-Positive Advanced Breast Cancer Jun 08, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Pembrolizumab With Chemo in Japanese TNBC Patients: KEYNOTE-355 Study Findings Jun 08, 2023
Breast Cancer Palbociclib as Adjuvant Therapy in Early Breast Cancer: PALLAS Trial Outcomes Jun 08, 2023
Breast Cancer Alpelisib+Fulvestrant vs. Real-World Standard Treatment for HR+, HER2-, PIK3CA-Mutated Breast Cancer Jun 08, 2023
